WHO Replenishment Model? — U.S. Hoarding of Ebola Drugs — Barriers to Care – POLITICO

Press play to listen to this article

Artificial intelligence speaks out.

— At the World Health Assembly today, Countries will discuss more sustainable ways of funding the World Health Organization.

— The U.S. stockpiles Ebola drugs, hampering access in countries that desperately need them. says Doctors Without Borders.

— Access to healthcare varies across Europe, but the Czech Republic is better in some respects. The EU Health System and Policy Observatory said:

Welcome to Thursday Morning Healthcare! We all strive to live sustainably. Now you can continue in the afterlife. A Dutch company grows coffins in molds using mycelium (mushroom root-like structures) and hemp fibers. It takes just a week to grow and 45 days to biodegrade when it’s under 6 feet. By comparison, a wooden coffin takes several years to grow and rot. Are we nearing the end? APs There are more.

contact: hcollis@politico.co.uk, cmartuscelli@politico.eu, afurlong@politico.co.uk, stbencharif@politico.eu and jroberts@politico.eu.please tweet @hcollis, @Carlo Martu, @Ashley Furlong, @Sarah Vencharif, @joanna_R

Sustainable WHO funding: Countries participating in the World Health Assembly (WHA) today discuss a potential replenishment model for funding the World Health Organization (WHO), an idea emerging from the Working Group on Sustainable Financing. be. This group helped shape the decision to increase assessed country contributions to the organization to his 50 percent of the core budget by the end of the decade (summary) here).

What it means: The WHO Secretariat was suggested The replenishment mechanism will have an investment round, with the first round expected to be held in late 2024, so as not to clash with other World Health Fund replenishment rounds in 2025 (thanks to the group we are looking at). going ahead…). The replenishment will last for four years, and the WHO Investor Forum will bring together countries and other organizations that normally fund the WHO to discuss the WHO’s work plans.

What else is going on at WHA today? Other agenda items include polio eradication, substandard and counterfeit medical products, and prevention of sexual exploitation, abuse and harassment within WHO.

bystander: In the morning, the Wellcome Trust will host an event on the infectious disease R&D ecosystem, while the Bill & Melinda Gates Foundation, Gabi, UNICEF and others will host events on building a world free of cervical cancer.

at lunch time, The official WHO roundtable, which aims to eliminate tuberculosis by 2030, will feature speakers from Zambia, Brazil and Indonesia, as well as WHO Hans Kluge and Polish Ambassador Zbigniew Czech. Outside Palais, you can visit events on health financing reform for the Global Fund, African Union and SADC. In the evening there is an event on African Union Health Security.See all other events here.

eye stain: Joy Poumapi, former Botswana health minister and now co-chair of the Global Preparedness and Monitoring Board (GPMB), said Wednesday at an event organized by the Pandemic Action Network and Spark Street Advisors that “the world needs prevention.” We are here today because we have repeatedly failed to prevent it,” he said. respond to pandemics. She said we shouldn’t wait for diplomats to agree a new treaty before confirming our readiness for the next health crisis. Instead, the GPMB asks countries to conduct simulation exercises to see how effective amendments to treaties and international health regulations are in practice before they are adopted.

no thanks: Dutch MP Rob Ruth (Conservative and Reform) his view He is clear about the pandemic treaty and fears that it will be administered by the WHO, an unelected body, and that the WHO will be too heavily influenced by China and Big Pharma.

Access to Ebola treatment: There are two treatments for Ebola, but access to them has stalled for more than two years after they were approved, Doctors Without Borders said in a paper. new report. The group says the U.S. emergency stockpile of Ebola drugs includes almost every drug currently available. “As a result, these treatments have not been adequately deployed as life-saving public health tools for people in countries experiencing outbreaks, and are largely left as biosecurity tools,” the report said. ing. The UN/WHO global stockpile is still under discussion, Médecins Sans Frontières says, and details such as its form, scale, governance and pricing are unknown.

R&D efforts: It is often argued that when research is publicly funded, the benefits should be affordable for everyone. “The role, scale and breadth of public donations are noteworthy, especially when it comes to care,” said the Doctors Without Borders report. [Ebola]In particular, they point to the publicly-funded Pamoja Turinde Maixa clinical trial, which showed excellent efficacy of two Ebola drugs.

**Message from PPTA: Compensating donors with a small fixed monetary allowance increases the amount of plasma collected, but does not affect plasma quality or PDMP safety. The European Medicines Agency will, regardless of whether the donor has compensation, Safety of plasma-derived drugs Not affected.**

EPC Position on Pharmaceutical Law: The pharmaceutical industry does not like the European Commission’s drug legislation proposals, but the industry may not have many other recourse, said Elizabeth Kuiper of the European Policy Center. her analysis of text.

Best friends with Beijing: An increasing number of companies are advertising rise of china As a base for innovative medicines. The subtext is clear. Part of it is to warn Europe against making the rules too strict to keep up with its main rivals in the R&D race. The other part is a reminder that if Brussels turns the screw too far against industry, it has greener pastures to uncamp. But Kuiper warns that China may not be the only one being cracked down. For example, the country ultimately supported TRIPS exemption for the COVID-19 vaccine.

you are stuck in the middle: Meanwhile, Morning Health notes that one traditional pharmaceutical powerhouse appears to be at least partly looking into this space.Biden administration’s anti-inflation law, which tightened negotiating provisions on Medicare, is welcomed with fear From an industry insider’s perspective.

Issues with generics in Europe: As for China, European drug makers have warned that a crisis in the Taiwan Strait could wreak havoc on the mainland’s drug supply. Over the past two decades, Europe has steadily outsourced the dirty business of generic drug manufacturing. Similar to pharmaceutical raw materials, many low-value-added generic drugs are now manufactured in Asia, and some are manufactured exclusively in China. But while these medicines aren’t as revolutionary or hugely profitable as cutting-edge branded treatments, they’re used routinely by patients and hospitals. Drug shortages experienced during the pandemic, or this winter, may give us an idea of ​​what much wider stockouts might look like in a geopolitical crisis.Other works by Carlo here.

Barriers to healthcare: European countries are often praised globally for their access to healthcare. But that doesn’t mean it’s accessible to everyone. In a webinar on Wednesday, Euout van Gineken of the European Health System and Policy Observatory outlined a long list of barriers to access to healthcare for patients across Europe.

Coverage Barrier: Does the person have insurance? Does the benefit package include all the benefits? he asked. “Even if we were ready to cover all this, there would be geographic barriers,” he said.

position: Perhaps the provider is too far away or the patient doesn’t have the transportation to get there, he said.

Organization: Once contacted by a healthcare provider, waiting lists and workforce issues can prevent patients from receiving care.

discrimination: “Even if they do make it to the doctor’s office, there can be problems with denial of care, perhaps due to discrimination or lack of ability to formulate their own care requests,” Van Gineken said. . Encountering any of these barriers “creates an unmet need,” he says.

Surprise Smile: In Spain, Portugal, Norway and Italy, dental “coverage is very limited,” says Julian Winkelmann of the European Health Systems and Policy Observatory. But in the Czech Republic, Austria and Germany, benefits are “very comprehensive and also cover dental cleanings, restorative care and prosthetics,” she said.

Czech Republic The name was also investigated as the co-payment of medicines was reduced. A woman in her 60s with comorbidities has a 20% risk of becoming a catastrophic spender in Bulgaria and about 10% in Germany, but only 4% in the Czech Republic. “Not only are fixed copayments and caps low, but there are exemptions for vulnerable groups,” said John Cyrus, also from the Observatory.

Light-on queue: Czech lawmakers also moved Wednesday to remove barriers to medical care for refugee children. Members of the Senate Health Committee voted unanimously in favor of recommending that the Senate approve changes to legislation affecting people entering Ukraine, including foreign minors enrolled in public health insurance. The pharmacy news agency reported that it was thrown. Zdravotnikidenik.

Private Gain: In the UK, more patients are going private as the National Health Service struggles with post-pandemic waiting lists and other pressures. State-of-the-art Private Health Information Network (PHIN) data This marks a record high of about 207,000 private medical hospital admissions in Q4 2022. This is driven by increased coverage and the use of private services by the NHS. The figures bring private enrollment to 820,000 in 2022, the highest since records began, and a 5% increase from pre-pandemic levels.

Among the beneficiaries are: British insurer Aviva reported on Wednesday that sales of private health insurance surged, rising 25 per cent to £33m in the first quarter of this year. FT. Amanda Blanc, CEO of Aviva, said: “The NHS is doing an amazing job for millions of people, but we want to help people who want faster treatment or if something happens to them. “Some people want to get treatment early because they are confident about it.” she said.

Return to starting point: The draft EU strategy on mental health is due to be released again on 7 June, according to a preliminary draft. agenda Committee report dated 23 May. changed Again, at Morning Health, we hope this sticks around for your mental health.

Tech billionaire injects son’s blood in search of youth Times.

status I’m pondering whether AI will soon be able to remotely diagnose the mental health of politicians.

Paralyzed man reports walking with brain-muscle reconnection device Guardian.

**Message from PPTA: Most countries provide some form of compensation for whole blood and plasma donations. This covers the costs incurred and recognizes any inconvenience associated with the donation. In four EU countries (Austria, Czech Republic, Germany and Hungary), private centers apply compensation as a flat rate allowance according to national law.in any form Compensation for plasma donors as implemented in the EU is consistent with the principle of ‘voluntary uncompensated donation’.‘.of Memorandum of the European Medicines Agency Or “It is important to recognize that a significant portion of the total plasma used in the production of PDMPs used in Europe comes from paid or paid donations. Soliciting uncompensated or uncompensated donors can lead to significant supply problems and product shortages without justification on safety grounds.”.**

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to content